Indications for LUMIGAN:
Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension.
≥16yrs: 1 drop in affected eye once daily in the PM.
<16yrs: not recommended.
Do not exceed recommended dose. Hepatic impairment. Ocular inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Contact lenses (remove; may reinsert lenses 15 mins after administration). Pregnancy (Cat.C). Nursing mothers.
Allow at least 5 mins between application of other topical ophthalmic agents.
Conjunctival hyperemia, ocular effects (eg, edema, hemorrhage, irritation, pain, pruritus), hypertrichosis, eyelash growth, visual disturbances, increased ocular pigmentation (iris, eyelid, eyelashes; may be permanent), other eyelash changes, keratitis, infection, abnormal liver function tests.
Soln—2.5mL, 5mL, 7.5mL